Prevalencia de síntomas de enfermedades respiratorias obstructivas, asma y EPOC, en mayores de 18 años de la República de Panamá [Prevalence of symptoms of obstructive respiratory diseases, asthma and COPD, in subject over 18 years old in Panama]

Author(s):  
Lorena Itzel Noriega ◽  
Joel Méndez

Resumen <br />Antecedentes. La prevalencia de las enfermedades como asma y la enfermedad pulmonar obstructiva crónica (EPOC), es variable en diferentes países. En Panamá, contamos con datos de prevalencia de asma en población infantil, pero no de adultos asmáticos ni de EPOC. Metodología. Se realiza un estudio de prevalencia de síntomas respiratorios, mediante la aplicación de una encuesta a nivel nacional por vía telefónica y medios digitales. Se realizó un muestreo estratificado por provincias. Se calcularon frecuencias absolutas y relativas para las preguntas del cuestionario. Objetivo: Determinar la prevalencia de síntomas de asma y EPOC en mayores de 18 años en la República de Panamá. Resultados. En el primer semestre del 2019, se evaluaron 1,514 encuestas con relación hombre: mujer de 1:1. La prevalencia de diagnóstico previo de asma o EPOC fue del 15,8% IC (14,0-17,7), sibilancias en los últimos 12 meses el 14,4% IC (12,6-16,2), despertares nocturnos un 18,2% IC (16,2-20,1), disnea el 15,8% IC (14,0-17,7) y bronquitis con resfriados el 19,3% IC (17,2-21,2). El 11,6 % IC (10,1-13,3) utiliza alguna medicación para asma, y el 10,1% IC (8,6-11,6) afirmó haber utilizado servicios de cuarto de urgencias. Respondieron afirmativo a síntomas de rinitis el 37,6% IC (35,2-40,1), historia de tabaquismo el 17,1% IC (15,2-19,0), y exposición a biomasa el 16,8% IC (14,9-18,7). Conclusiones. Los síntomas de asma y EPOC más prevalentes fueron; opresión en el pecho o bronquitis con los resfriados, despertares nocturnos por falta de aire tos u opresión en el pecho y sibilancias en algún momento del día. Los síntomas de rinitis fueron los más prevalentes en los sujetos encuestados presentándose en más de un tercio de la muestra. Los antecedentes de tabaquismo, exposición pasiva al humo del tabaco y la exposición a humo de leña, también variaron según condición, pero en ninguno de los casos superó una quinta parte de los encuestados. El uso de medicamentos fue porcentualmente menor a la cantidad de sujetos que refirió haber recibido diagnóstico previo de asma o de EPOC. Uno de cada diez encuestados indicó haber visitado servicios de urgencias por pecho apretado, falta de aire o tos, en el último año. <br /><br />Abstract<br />Background. The prevalence of diseases such as asthma and chronic obstructive pulmonary disease (COPD), is variable in different countries. In Panama, we have data on the prevalence of asthma in children, but not in adults with asthma or COPD. Methodology. A study of prevalence of respiratory symptoms is carried out, through the application of a nationwide survey by telephone and digital means. A stratified sampling was carried out by provinces. Absolute and relative frequencies were calculated for the questions of the questionnaire. Objective: To determine the prevalence of asthma and COPD symptoms in subject over 18 years old in the Panama Republic. Results. In the first semesters of 2019, 1,514 surveys evaluated with a 1: 1 male: female ratio. The prevalence of previous diagnosis of asthma or COPD was 15.8% CI (14,0-17,7), wheezing in the last 12 months 14.4% CI (12,6-16,2), night awakenings 18.2% CI (16,2-20,1), dyspnea 15.8% CI (14,0-17,7) and bronchitis with colds 19.3% CI (17,2-21,2). 11.6% CI (10, 1-13,3) used some medication for asthma and 10.1% CI (8,6-11,6) stated that they had used emergency room services. 37.6% CI (35,2-40,1), a history of smoking 17.1% CI (15,2-19,0),and exposure to biomass 16.8% CI (14,9-18,7) responded affirmatively to symptoms of rhinitis. Conclusions. The most prevalent asthma and COPD symptoms were; tightness in the chest or bronchitis with colds, nighttime awakenings due to shortness of breath or tightness in the chest and wheezing at any time of the day. Rhinitis symptoms were the most prevalent in the surveyed subjects, appearing in more than a third of the sample.Smoking history, passive exposure to tobacco smoke, and exposure to wood smoke also varied by condition, but in none of the cases did it exceed a fifth of those surveyed. The use of medications was percentage lower than the number of subjects who reported having received a previous diagnosis of asthma or COPD. One in ten respondents has received emergency services for a tight chest, shortness of breath, or cough in the past year.<br /><br />

2016 ◽  
Vol 2016 ◽  
pp. 1-7 ◽  
Author(s):  
Linda Lee ◽  
Tejal Patel ◽  
Loretta M. Hillier ◽  
James Milligan

Background. Chronic Obstructive Pulmonary Disease (COPD) is underdiagnosed in primary care.Aim. To explore the utility of proactive identification of COPD in patients 75 years of age and older in a Canadian primary care setting.Methods.Canadian Thoracic Society (CTS) screening questions were administered to patients with a smoking history of 20 pack-years or more; those with a positive screen were referred for postbronchodilator spirometry.Results. A total of 107 patients (21%), of 499 screened, had a 20-pack-year smoking history; 105 patients completed the CTS screening. Forty-four (42%) patients were positive on one or more questions on the screening; significantly more patients with a previous diagnosis of COPD (64%) were positive on the CTS compared to those without a previous diagnosis of COPD (30%). Of those who were not previously diagnosed with COPD (N= 11), four (36%) were newly diagnosed with COPD.Conclusion. A systematic two-stage method of screening for COPD, using CTS screening questions followed by spirometric confirmation, is feasible in the context of a busy primary care setting. More research is needed to assess the value of restricting screening to patients with a smoking history of 20 pack-years and on the sensitivity and specificity of these measures.


2021 ◽  
Vol 04 (10) ◽  
pp. 01-03
Author(s):  
Ehsan Khalilipur

An 80-year-old lady was referred to our cardiology emergency department with complaints of increasing shortness of breath since 45 days earlier, which had gradually worsened over the last week. She had a history of chronic obstructive pulmonary disease, diabetes mellitus, hypertension and chronic kidney disease


PLoS ONE ◽  
2021 ◽  
Vol 16 (8) ◽  
pp. e0256121
Author(s):  
Ahmed Ddungu ◽  
Fred C. Semitala ◽  
Barbara Castelnuovo ◽  
Christine Sekaggya-Wiltshire ◽  
William Worodria ◽  
...  

Introduction In the last decade, survival of people living with HIV (PLHIV) has dramatically increased due wide availability of effective antiretroviral therapy. However, PLHIV remain at a comparatively higher risk of non-communicable comorbidities. We sought to determine the burden of COPD and its associations in an urban tertiary HIV clinic in Uganda. Methods and findings HIV-infected adults attending the Makerere University Joint AIDS program; aged ≥30 years without acute ailments were screened for COPD using study questionnaires and spirometry (post-bronchodilator FEV1/FVC<0.7). We determined its prevalence and association with demographic characteristics, body mass index (BMI) and known risk factors. Of 288 participants enrolled, 177 (61%) were female; 253 (88%) were from urban residences, median age was 45 years (IQR: 39–51), 71(25%) were ‘ever’ smokers, 284(99%) reported biomass fuel use and 72(25%) had a history of tuberculosis. All except 1 participant were on antiretroviral therapy, median current CD4 (cells/mm3) was 558 (IQR 402–753) and 275(96%) were virologically suppressed. Nearly half (130/288, 45%) had recurrent respiratory symptoms. The prevalence of COPD was 3.1% (9/288) [95% CI: 1.63–5.92]. COPD was associated with: previous tuberculosis, (adjusted odds ratio (AOR): 6.36, [95% CI 1.64–35.84], P = 0.036), self-reported chronic shortness of breath (AOR: 9.06, [95% CI 1.34–61.10], P = 0.024) and a BMI <21 Kg/m2 (AOR: 10.42 [95% CI: 1.61–100.00], P = 0.013). Conclusion In this HIV population, COPD prevalence was low and was associated with previous tuberculosis, self-reported chronic shortness of breath and BMI <21 Kg/m2.


Healthcare ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 53
Author(s):  
Jun Horie ◽  
Koichiro Takahashi ◽  
Shuuichi Shiranita ◽  
Kunihiko Anami ◽  
Shinichiro Hayashi

This study’s objective was to examine the characteristics of patients with chronic obstructive pulmonary disease (COPD) presenting with various exercise tolerance levels. A total of 235 patients with stable COPD were classified into 4 groups: (1) LoFlo + HiEx—patients with a six-minute walking distance (6MWD) ≥350 m and percentage of predicted forced expiratory volume in 1 s (%FEV1.0) <50%; (2) HiFlo + HiEx—patients with a 6MWD ≥350 m and a %FEV1.0 ≥50%; (3) LoFlo + LoEx—patients with a 6MWD < 350 m and %FEV1.0 < 50%; and (4) HiFlo + LoEx—patients with a 6MWD <350 m and %FEV1.0 ≥ 50%. Aspects of physical ability in the HiFlo + LoEx group were significantly lower than those in the HiFlo + HiEx group. The HiFlo + LoEx group was characterized by a history of hospitalization for respiratory illness within the past year, treatment with at-home oxygen therapy, and lacking daily exercise habits. Following three months of pulmonary rehabilitation, the LoFlo + HiEx group significantly improved in the modified Medical Research Council dyspnea score, maximum gait speed, and 6MWD, while the HiFlo + LoEx group significantly improved in the percentage of maximal expiratory pressure, maximum gait speed, 6MWD, incremental shuttle walking distance, and St. George’s Respiratory Questionnaire score. The HiFlo + LoEx group had the greatest effect of three-month pulmonary rehabilitation compared to other groups.


2021 ◽  
Vol 12_suppl ◽  
pp. 204062232110245
Author(s):  
Yuh-Chin Tony Huang ◽  
Marion Wencker ◽  
Bastiaan Driehuys

Imaging modalities such as plain chest radiograph and computed tomography (CT) are important tools in the assessment of patients with chronic obstructive pulmonary disease (COPD) of any etiology. These methods facilitate differential diagnoses and the assessment of individual lung pathologies, such as the presence of emphysema, bullae, or fibrosis. However, as emphysema is the core pathological consequence in the lungs of patients with alpha-1 antitrypsin deficiency (AATD), and because AATD is associated with the development of other lung pathologies such as bronchiectasis, there is a greater need for patients with AATD than those with non-AATD-related COPD to undergo more detailed assessment using CT. In the field of AATD, CT provides essential information regarding the presence, distribution, and morphology of emphysema. In addition, it offers the option to quantify the extent of emphysema. These data have implications for treatment decisions such as initiation of alpha-1 antitrypsin (AAT) therapy, or suitability for surgical or endoscopic interventions for reducing lung volume. Furthermore, CT has provided vital insight regarding the natural history of emphysema progression in AATD, and CT densitometry has underpinned research into the efficacy of AAT therapy. Moving forward, hyperpolarized xenon gas (129Xe) lung magnetic resonance imaging (MRI) is emerging as a promising complement to CT by adding comprehensive measures of regional lung function. It also avoids the main disadvantage of CT: the associated radiation. This chapter provides an overview of technological aspects of imaging in AATD, as well as its role in the management of patients and clinical research. In addition, perspectives on the future potential role of lung MRI in AATD are outlined.


Author(s):  
So-Young Kim ◽  
Chang-Ho Lee ◽  
Dae-Myoung Yoo ◽  
Chan-Yang Min ◽  
Hyo-Geun Choi

This study explored the relation between Ménière’s disease and chronic obstructive pulmonary disease (COPD). The ≥40-year-old population of the Korean National Health Insurance Service-Health Screening Cohort was included. In total, 7734 Ménière’s disease patients and 30,936 control participants were enrolled. Control participants were matched for age, sex, income, and region of residence with Ménière’s disease participants. The odds of having Ménière’s disease given a history of COPD were analyzed using conditional logistic regression. Subgroup analyses were conducted according to age, sex, income, and region of residence. The odds of having Ménière’s disease were found to be 1.18-fold higher with a history of COPD than with no history of COPD (95% confidence intervals (CI) = 1.06–1.32, E-value (CI) = 1.64 (1.31)). The ≥60 years old, male, low-income, and rural subgroups showed increased odds of developing Ménière’s disease when a history of COPD was reported. A history of COPD was associated with an increased risk of Ménière’s disease in the adult population.


2015 ◽  
Vol 22 (4) ◽  
pp. 209-214 ◽  
Author(s):  
Chantal Robitaille ◽  
Esther Dajczman ◽  
Andrew M Hirsch ◽  
David Small ◽  
Pierre Ernst ◽  
...  

BACKGROUND: Targeted spirometry screening for chronic obstructive pulmonary disease (COPD) has been studied in primary care and community settings. Limitations regarding availability and quality of testing remain. A targeted spirometry screening program was implemented within a presurgical screening (PSS) clinic to detect undiagnosed airways disease and identify patients with COPD/asthma in need of treatment optimization.OBJECTIVE: The present quality assurance study evaluated airflow obstruction detection rates and examined characteristics of patients identified through the targeted screening program.METHODS: The targeted spirometry screening program was implemented within the PSS clinic of a tertiary care university hospital. Current or ex-smokers with respiratory symptoms and patients with a history of COPD or asthma underwent prebronchodilator spirometry. History of airways disease and smoking status were obtained during the PSS assessment and confirmed through chart reviews.RESULTS: After exclusions, the study sample included 449 current or ex-smokers. Abnormal spirometry results were found in 184 (41%) patients: 73 (16%) had mild, 93 (21%) had moderate and 18 (4%) had severe or very severe airflow obstruction. One hundred eighteen (26%) new cases of airflow obstruction suggestive of COPD were detected. One-half of these new cases had moderate or severe airflow obstruction. Only 34% of patients with abnormal spirometry results had reported a previous diagnosis of COPD. More than one-half of patients with abnormal spirometry results were current smokers.CONCLUSIONS: Undiagnosed airflow obstruction was detected in a significant number of smokers and ex-smokers through a targeted screening program within a PSS clinic. These patients can be referred for early intervention and secondary preventive strategies.


Open Heart ◽  
2018 ◽  
Vol 5 (2) ◽  
pp. e000848 ◽  
Author(s):  
Andreas Jönsson ◽  
Artur Fedorowski ◽  
Gunnar Engström ◽  
Per Wollmer ◽  
Viktor Hamrefors

ObjectiveChronic obstructive pulmonary disease (COPD) and coronary artery disease (CAD) are leading causes of global morbidity and mortality. Despite the well-known comorbidity between COPD and CAD, the presence of COPD may be overlooked in patients undergoing coronary evaluation. We aimed to assess the prevalence of undiagnosed COPD among outpatients evaluated due to suspected myocardial ischemia.MethodsAmong 500 outpatients who were referred to myocardial perfusion imaging due to suspected stable myocardial ischaemia, 433 patients performed spirometry. Of these, a total of 400 subjects (age 66 years; 45% women) had no previous COPD diagnosis and were included in the current study. We compared the prevalence of previously undiagnosed COPD according to spirometry criteria from The Global Initiative for Chronic Obstructive Lung Disease (GOLD) or lower limit of normal (LLN) and reversible myocardial ischaemia according to symptoms and clinical factors.ResultsA total of 134 (GOLD criteria; 33.5 %) or 46 patients (LLN criteria; 11.5%) had previously undiagnosed COPD, whereas 55 patients (13.8 %) had reversible myocardial ischaemia. The presenting symptoms (chest discomfort, dyspnoea) did not differ between COPD, myocardial ischaemia and normal findings. Except for smoking, no clinical factors were consistently associated with previously undiagnosed COPD.ConclusionsAmong middle-aged outpatients evaluated due to suspected myocardial ischaemia, previously undiagnosed COPD is at least as common as reversible myocardial ischaemia and the presenting symptoms do not differentiate between these entities. Patients going through a coronary ischaemia evaluation should be additionally tested for COPD, especially if there is a positive history of smoking.


2016 ◽  
Vol 29 (5) ◽  
pp. 340
Author(s):  
Cátia Oliveira Matos ◽  
Manuel Mário Sousa

Foreign body aspiration is common in children and in the elderly, who may present with subtle symptoms. Clinical suspicion is crucial and bronchoscopy is the main diagnostic and therapeutic procedure available. This is the case of a man, 78 years old, with a history of chronic obstructive pulmonary disease, who presented with respiratory distress following oral intake of tablets. History taking and physical examination raised suspicion. The diagnosis was confirmed with flexible bronchoscopy and rigid bronchoscopy was carried out for treatment. The patient’s condition is stable and he is under investigations for dysphagia.


Sign in / Sign up

Export Citation Format

Share Document